Comparison
Cafeity compared with Glapp
Glapp describes itself as the first community-driven GLP-1 app, built by people on the medication. It overlaps with Cafeity more than most — both track shots, side effects and food noise — and then goes somewhere Cafeity deliberately does not: predictions, and comparisons with other people.
Where Glapp is ahead
Glapp runs on iPhone, iPad, Android and in a web browser; Cafeity is iPhone-only. It has been on the App Store since March 2026 and has 925 ratings averaging 4.7 stars, while Cafeity launched on 21 September 2026 and has none yet. It keeps a full medication inventory — vials, pens, concentration, volume and beyond-use dates — that deducts each dose as you log it. If you need Android or the web, or you want to see your progress against other people on the same medicine, Glapp is the better fit.
Side by side
| Cafeity | Glapp | |
|---|---|---|
| Platforms | iPhone (iOS 17 or later) | iPhone and iPad (iOS 17 or later), Android and web |
| Languages | English | English |
| App Store rating | New — no ratings yet | 4.7 from 925 ratings |
| Price | Free to download; logging is free with 90 days of history; Cafeity Pro is an optional subscription | Free to download; its website describes it as a free app |
| Dose record | Doses, sites on a body map, full history, reminders you set | Dose, timing and injection site |
| Food noise and hunger | Logged as symptoms, on the same timeline as doses and meals | Food-noise and hunger levels, tracked against each dose |
| Daily check-in | Symptoms, mood and bowel changes, logged when they happen | Side effects, cravings, mood, energy, bowel movements and sleep quality |
| Estimated medication level | The Cycle View (Pro), labelled on screen as an estimate | A curve for semaglutide and tirzepatide |
| Predictions | None — it describes your record and never forecasts | "Shot phases" that its listing says predict hunger, cravings and energy shifts |
| Comparison with others | None | Progress compared with clinical trial data and with other users |
| Questions answered | Ora answers questions about your own record (Pro) | "Wisdom" answers general GLP-1 questions from published research |
| Supply | A recorded supply count with an optional low-supply reminder | A full inventory of vials and pens, deducted as doses are logged |
| Dose calculators | None, by design | A tirzepatide dose calculator on its website that converts milligrams to syringe units |
| Report | Visit Summary — one print-ready page for your prescriber | A weekly progress report |
| Where health data lives | Your device and your own account; never stored in iCloud | Encrypted; never sold or shared; synced across devices |
| Medication naming | Generic names only | Brand names used throughout its listing |
Predictions and comparisons are the real difference
Glapp's shot phases forecast hunger and energy across the week, and its reports set your progress against trial results and against other people on the same medicine and dose. Some people find that motivating, and Glapp is built for them. Cafeity works to the opposite rule: it describes what has already happened in your own record and never forecasts. Trial results are averages across hundreds or thousands of people — see how trial results are reported — and a comparison with strangers can make an ordinary week feel like a failure. Neither approach is wrong; they suit different people.
Doses are where Cafeity stops
Glapp's website offers a calculator that converts a tirzepatide dose into syringe units. Cafeity will never calculate, convert or time a dose. Those numbers belong to your prescriber and pharmacist, and mistakes with them cause real harm — the FDA has warned about exactly these errors with compounded products (see compounded GLP-1s).
Where your data lives
Glapp says your data is encrypted, never sold or shared, and deletable at any time, and it syncs across its apps and the web. Cafeity keeps health data on the device and in your own account under per-record permissions, never in iCloud and never for advertising, with full export and deletion. Read both privacy policies.
What Cafeity looks like
Not affiliated
Cafeity is an independent product, not affiliated with, endorsed by or sponsored by Glapp or any pharmaceutical manufacturer. All trademarks belong to their owners.
Where these claims come from
- Glapp on the App Store Listing and ratings, checked 2026-09-24: 4.74 average from 925 ratings; first released 22 March 2026; requires iOS 17.0 or later; English. Source of the feature descriptions above.
- glapp.io Availability on iPhone, iPad, Android and the web; "free"; comparisons with clinical trials and other users; privacy statements.
- Glapp tirzepatide dose calculator The calculator that converts milligrams per millilitre to syringe units.
- Glapp privacy policy For the full detail of how Glapp handles data.